TLR8, toll like receptor 8, 51311

N. diseases: 122; N. variants: 8
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Respiratory Distress Syndrome, Adult
0.010 Biomarker disease BEFREE In humans with Acute Respiratory Distress Syndrome (ARDS), we describe a potential role for TLR8 activation by circulating RNA ligands, as plasma and extracted RNA fractions from ARDS subjects activated TLR8 in vitro. 31385713 2020
CUI: C2062441
Disease: Influenza A
Influenza A
0.010 Biomarker disease BEFREE The TCR-independent methods include direct stimulation with the recombinant cytokines IL-12 and IL-18, and indirect stimulation with TLR-4/TLR-8 agonists or influenza A virus in the presence of APCs. 31792818 2020
CUI: C0010246
Disease: Coxsackievirus Infections
Coxsackievirus Infections
0.010 Biomarker group BEFREE TLR8, an endosomal receptor, can recognize single-stranded RNA viruses, such as influenza virus, Sendai virus, Coxsackie B virus, HIV, and HCV. 31526944 2019
CUI: C0021400
Disease: Influenza
Influenza
0.010 Biomarker disease BEFREE TLR8, an endosomal receptor, can recognize single-stranded RNA viruses, such as influenza virus, Sendai virus, Coxsackie B virus, HIV, and HCV. 31526944 2019
CUI: C0024530
Disease: Malaria
Malaria
0.010 Biomarker disease BEFREE Altogether, our data are the first reported activation of TLR8 by protozoan RNA and demonstrate both the critical role of TLR8 in human blood-stage malaria and its unique functionality in the human immune system. 30972055 2019
CUI: C0031099
Disease: Periodontitis
Periodontitis
0.010 GeneticVariation disease BEFREE In male participants, reduced susceptibility to periodontitis was observed in carriers of TLR7-rs3853839 (CC versus GG and CG, P = 0.02, OR 0.30, 95% CI 0.11-0.85) and TLR8-rs3764879 (CC versus GG and CG, P = 0.02, OR 0.31, 95% CI 0.12-0.82). 30517775 2019
CUI: C0032285
Disease: Pneumonia
Pneumonia
0.010 Biomarker disease BEFREE We here used a recently developed chemical antagonist of TLR8 to determine its role in human primary monocytes challenged with <i>S. aureus</i>, GBS, <i>Streptococcus pneumonia, Pseudomonas aeruginosa</i>, and <i>E. coli</i>. 31214180 2019
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
0.010 Biomarker disease BEFREE We conclude that p53 can strongly influence TLR8-mediated immune responses and that knowledge of the p53-responsive SNP can inform diagnosis and prognosis of RSV disease and other diseases that might have a TLR8 component, including cancer. 31430261 2019
CUI: C0009319
Disease: Colitis
Colitis
0.010 Biomarker disease BEFREE In this study, we found that <i>Il1f6</i><sup>-/-</sup> mice developed milder psoriasiform dermatitis upon treatment with imiquimod, a ligand for TLR ligand 7 (TLR7) and TLR8, whereas <i>Il1f6</i><sup>-/-</sup> mice showed similar susceptibility to dextran sodium sulfate-induced colitis to wild-type mice. 29794016 2018
CUI: C0024117
Disease: Chronic Obstructive Airway Disease
Chronic Obstructive Airway Disease
0.010 Biomarker disease BEFREE Association of HJURP, MCRS1 and TLR8 are novel in relation to COPD. 29871630 2018
CUI: C0025048
Disease: Meconium Aspiration Syndrome
Meconium Aspiration Syndrome
0.010 AlteredExpression phenotype BEFREE Compared with controls, TLR1 and TLR4 were highly expressed, TLR9 was moderately expressed, TLR7 was weakly expressed and TLR8 expression was neutral in neonates with MAS. 29095429 2018
CUI: C0151332
Disease: Active tuberculosis
Active tuberculosis
0.010 GeneticVariation disease BEFREE The A-allele of TLR8 rs3764880 SNP was protective against the development of TB in males (A vs G, OR = 0.58, 95%CI = 0.37-0.91). 30424735 2018
CUI: C0262985
Disease: Psoriasiform eczema
Psoriasiform eczema
0.010 Biomarker disease BEFREE In this study, we found that <i>Il1f6</i><sup>-/-</sup> mice developed milder psoriasiform dermatitis upon treatment with imiquimod, a ligand for TLR ligand 7 (TLR7) and TLR8, whereas <i>Il1f6</i><sup>-/-</sup> mice showed similar susceptibility to dextran sodium sulfate-induced colitis to wild-type mice. 29794016 2018
CUI: C0278996
Disease: Malignant Head and Neck Neoplasm
Malignant Head and Neck Neoplasm
0.010 Biomarker disease BEFREE Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid Signals. 29061643 2018
Cervical intraepithelial neoplasia grade 2
0.010 AlteredExpression disease BEFREE Six women with CIN2 regression, who presented with an HR-HPV DNA-negative CIN2 lesion at study entry, had significantly higher baseline levels of TLR2 (p = 0.005), TLR7 (p = 0.013) and TLR8 (p = 0.012), compared to women with CIN2 persistence/progression, suggesting their role in clearance of HPV prior to clearance of the lesion. 30121951 2018
CUI: C0751356
Disease: Idiopathic Inflammatory Myopathies
Idiopathic Inflammatory Myopathies
0.010 AlteredExpression disease BEFREE Toll-like receptor 7 (TLR-7), TLR-8, and interferon (IFN)-induced genes are expressed in patients with idiopathic inflammatory myositis. 29569859 2018
CUI: C1861453
Disease: Pseudohyperkalemia Cardiff
Pseudohyperkalemia Cardiff
0.010 GeneticVariation disease BEFREE Carriage of the C allele in three SNPs of TLR3 (rs3775290, rs3775291, and rs5743312), the C allele in TLR7 (rs3853839) in females only, and the C allele in TLR8 (rs3764879) in males only were significantly higher in SVC group than CHC group (P < 0.001), while carriage of the T allele in TLR7 (rs179008) in females only and the A allele in TLR8 (rs3764880) in both males and females were significantly higher in CHC infection more than SVC group (P < 0.001). 29947302 2018
CUI: C3887461
Disease: Head and Neck Carcinoma
Head and Neck Carcinoma
0.010 Biomarker disease BEFREE Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid Signals. 29061643 2018
CUI: C0002395
Disease: Alzheimer's Disease
Alzheimer's Disease
0.010 Biomarker disease BEFREE Data herein indicating that proinflammatory cytokines are reduced, whereas IFN-λ production and TLR8 and 9 MFI are augmented in those aMCI in whom AD conversion is not observed suggest that the ability to mount stronger antiviral response within an antiiflammatory milieu associates with lack of AD conversion. 29196629 2017
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.010 Biomarker disease BEFREE We hypothesized that specific TLR members (TLR2, TLR3, TLR4, TLR8) may play a role in atherosclerosis progression and its accompanying inflammatory response. 28478461 2017
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.010 Biomarker disease BEFREE We hypothesized that specific TLR members (TLR2, TLR3, TLR4, TLR8) may play a role in atherosclerosis progression and its accompanying inflammatory response. 28478461 2017
CUI: C0018572
Disease: Hand, Foot and Mouth Disease
Hand, Foot and Mouth Disease
0.010 AlteredExpression disease BEFREE The results of our study seem to indicate that the high expression levels of TLR3, TLR4, TLR7 and TLR8 induced in severe EV71 HFMD regulate the expression of cytokines by MAPK signaling pathway and negatively affect the ability of the organism to resolve the infection. 28565836 2017
CUI: C0025202
Disease: melanoma
melanoma
0.010 AlteredExpression disease BEFREE High gene expression of TLR7 and TLR8 in melanoma tumors is associated with high expression levels of functional markers of immune cells, which predicts longer overall survival of patients with melanoma. 28919783 2017
CUI: C0028754
Disease: Obesity
Obesity
0.010 Biomarker disease BEFREE Our data shows a positive feedback loop between blood monocytes and obese omental AT, which releases chemotactic mediators and TLR8-enriched MP, thus inducing an up-regulation of CD16<sup>+</sup> monocytes, favoring leukocyte infiltration in the obese omental AT. 27677832 2017
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.010 Biomarker group BEFREE These results indicate that paeonol suppresses the maturation and activation of DCs by decreasing MyD88 and TLR8 proteins in the TLR7/8 signaling pathway which finally alleviates psoriasis‑like skin lesions. 28339016 2017